Trial finds benefit for GLP-1 agonist in Parkinson’s April 4, 2024 AutoBot News 0 A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug class.